a
a
Weather:
No weather information available
HomeHealthNOBLES MEDICAL TECHNOLOGY II ANNOUNCES FDA APPROVAL TO RESTART NOBLESTITCH™ CLINICAL TRIAL

NOBLES MEDICAL TECHNOLOGY II ANNOUNCES FDA APPROVAL TO RESTART NOBLESTITCH™ CLINICAL TRIAL

LAS VEGAS, Oct. 7, 2025 /PRNewswire/ — Nobles Medical Technology II, a pioneering leader in innovative cardiovascular closure solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted approval to restart its pivotal NobleStitch™ clinical trial, marking an…

No comments

Sorry, the comment form is closed at this time.

Translate »